NextCure (NXTC) Financial Statements

321 Followers

NextCure Financial Overview

NextCure's market cap is currently $31.76M. The company's EPS TTM is $-21.9; its P/E ratio is -1.32; NextCure is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -2.19M	$ -2.87M	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -57.62M	$ -59.75M	$ -67.64M	$ -75.91M	$ -70.77M
EBITDA	$ -55.43M	$ -54.34M	$ -63.95M	$ -71.78M	$ -66.59M
Net Income	$ -55.84M	$ -55.65M	$ -62.72M	$ -74.73M	$ -69.39M
Balance Sheet
Cash & Short-Term Investments	$ 41.82M	$ 68.62M	$ 108.30M	$ 159.91M	$ 219.59M
Total Assets	$ 50.18M	$ 80.86M	$ 128.04M	$ 184.16M	$ 242.39M
Total Debt	$ 4.15M	$ 5.95M	$ 6.61M	$ 7.12M	$ 0.00
Net Debt	$ -21.83M	$ -21.78M	$ -6.48M	$ -19.51M	$ -12.34M
Total Liabilities	$ 15.24M	$ 15.39M	$ 13.62M	$ 16.63M	$ 9.00M
Stockholders' Equity	$ 34.94M	$ 65.47M	$ 114.42M	$ 167.53M	$ 233.39M
Cash Flow
Free Cash Flow	$ -49.61M	$ -41.28M	$ -53.79M	$ -56.00M	$ -59.60M
Operating Cash Flow	$ -49.61M	$ -40.80M	$ -52.97M	$ -53.89M	$ -57.24M
Investing Cash Flow	$ 25.56M	$ 55.31M	$ 39.27M	$ 67.98M	$ 36.60M
Financing Cash Flow	$ 22.31M	$ 144.00K	$ 154.00K	$ 200.00K	$ -3.27M

Currency in USD

NextCure Earnings and Revenue History

Income Statement >

NextCure Debt to Assets

Balance Sheet >

NextCure Cash Flow

Cash Flow >

NextCure Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >